Topic: regenerative medicine
Pluristem and Thermo Fisher will collaborate to scale up manufacturing of regenerative medicines, to build an industry capable of millions of doses.
MiMedx has replaced its president and its CEO after ongoing investigations into its accounting and compliance practices.
Researchers from King's College London designed a gene therapy that can be switched off once it has treated a spinal cord injury.
Fresenius signed a $150 million global commercialization deal with Humacyte for its regenerative blood vessel implant and bought 19% of the company.
UC San Francisco scientists used a process called synNotch signaling to prompt individual cells to form tissue structures.
PolarityTE, offering scant details, acquired an unnamed CRO to expand its R&D programs and appointed a new veterinary officer.
Computational modeling predicted how tissue-engineered heart valves change in the body, allowing researchers to design customized valves.
The latest in biotech research includes a new way to grow human heart muscle and uncovering a genetic abnormality at the root of ALS and dementia.
A trial of a retinal implant built from embryonic stem cells produced encouraging results in patients with dry age-related macular degeneration.
Recent biotech discoveries include a compound that interrupts neuropathic pain and a strategy for preventing drug- or noise-induced hearing loss.